Archives mensuelles : janvier 2013

Lactobacillus Fermented Foods Made Of Sesame, Soybean And Konbu May Enhance Resistance To Harmful Bacterial Infection

Suntory delivered a presentation on Gozugon, a food made of sesame, soybean and konbu (dried kelp) and fermented by plant-derived Lactobacillus pentosus S-PT84, at the 60th Annual Meeting of the Japanese Society of Nutrition and Food Science. The company reported … Lire la suite

Publié dans Uncategorized | Laisser un commentaire

Phase III Studies Showed ISENTRESS(R) In Combination Therapy Provided Significant Viral Load Reductions

In new subgroup analyses of a Phase III study (STARTMRK) that compared Merck & Co., Inc.’s integrase inhibitor ISENTRESS® (raltegravir) to efavirenz [one of the leading antiretrovirals prescribed for previously untreated (treatment-naГЇve) HIV-infected patients], ISENTRESS was found to be as … Lire la suite

Publié dans Uncategorized | Laisser un commentaire

Conscious Man Has Breakthrough Brain Surgery

In a world’s first, a man in Canberra, Australia, was awake during an operation to have an aneurism removed from a vein in his brain. The aneurism was affecting his vision and giving him dizzy spells. Despite its precarious location, … Lire la suite

Publié dans Uncategorized | Laisser un commentaire

Former SA Deputy President’s Remarks About HIV/AIDS Anger Educators

Comments about HIV/AIDS made by former South African Deputy President Jacob Zuma during his rape trial earlier this week « have angered [HIV/]AIDS educators, » BBC News reports (BBC News, 4/5). Zuma, a former chair of South Africa’s AIDS Council, currently is … Lire la suite

Publié dans Uncategorized | Laisser un commentaire

Human Cells In The Gut Can Neutralize Toxic Effects Of C. Difficile, A Common Hospital-acquired Infection

Human cells in the gut can release molecules that neutralize the toxic effects of Clostridium difficile (C. difficile) infection, a common hospital-acquired infection. The researchers, from David Geffen School of Medicine at UCLA and the University of Texas Medical Branch … Lire la suite

Publié dans Uncategorized | Laisser un commentaire

5-In-1 Pediatric Combination For Immunization Against Diphtheria, Tetanus, Pertussis, Polio And Haemophilus Influenzae Type B Licenced By US FDA

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, has announced that the U.S. Food and Drug Administration (FDA) has licensed Pentacel®, Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine. … Lire la suite

Publié dans Uncategorized | Laisser un commentaire

To Improve TB Testing, Nanobiotechnology Experts Join Forces

Two UK companies have been awarded joint funding for a research project that could see significant advances in the quest to aid detection and eradication of Tuberculosis (TB), across the world. The National Physical Laboratory (NPL) and Orla Protein Technologies … Lire la suite

Publié dans Uncategorized | Laisser un commentaire

Some Colombian Health Insurance Companies Have Refused To Provide HIV/AIDS Related-Services, IRIN/PlusNews Reports

Although the Colombian government mandates that private health companies provide essential services, including those related to HIV/AIDS treatment, care and prevention, many have refused to do so, and critics of the country’s national health insurance system argue there is no … Lire la suite

Publié dans Uncategorized | Laisser un commentaire

Male Circumcision Opponents Seek To Outlaw Practice Despite Possible Benefits in Lowering Risk of HIV Transmission

Opponents of male circumcision have begun lobbying the United Nations to classify the practice as a human rights violation despite the recent release of a study showing that the practice might reduce the risk of female-to-male HIV transmission, the… Religion … Lire la suite

Publié dans Uncategorized | Laisser un commentaire

Rib-X Pharmaceuticals Initiates Two Phase 2 Studies For Novel Antibiotic Compound RX-1741

Rib-X Pharmaceuticals, Inc. (« Rib-X » or the « Company »), a biopharmaceutical company focused on the development of novel antibiotics for the treatment of antibiotic-resistant infections, announced the enrolment of the first patients in two separate Phase 2 clinical trials. The studies will … Lire la suite

Publié dans Uncategorized | Laisser un commentaire